Science holds true despite lure of fame
Tuesday, 23 March 2010
Amanda Ellis
ALTHOUGH Hollywood fame and fortune shines brightly in Biosignal?s future, its shareholders have rejected a motion to offload its anti-biofilm assets to now-delisted NASDAQ company Commonwealth Biotechnologies.
Anyone a member?
http://www.biotechnologynews.net/storyview.asp?storyid=1133728§ionsource=